Vimovo and Pleurisy - a phase IV clinical study of FDA data
We study 17,493 people who take Vimovo or have Pleurisy. No report of Pleurisy is found in people who take Vimovo.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Vimovo?
Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in back pain. eHealthMe is studying from 9,114 Vimovo users for its effectiveness, alternative drugs and more.
What is Pleurisy?
Pleurisy (inflammation of the pleurae, which causes pain when breathing) is found to be associated with 1,531 drugs and 1,060 conditions by eHealthMe.
Do you take Vimovo and have Pleurisy?Check whether Pleurisy is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Pleurisy and when was it recovered:
Expand to all the drugs that have ingredients of esomeprazole magnesium; naproxen:
Alternative drugs to, pros and cons of Vimovo:
- Vimovo (9,114 reports)
Pleurisy treatments and more:
- Pleurisy (8,379 reports)
COVID vaccines that are related to Pleurisy:
- Pleurisy in Moderna COVID Vaccine
- Pleurisy in Pfizer BioNTech Covid Vaccine
- Pleurisy in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Pleurisy:
All the conditions that are associated with Pleurisy:
How the study uses the data?
The study uses data from the FDA. It is based on esomeprazole magnesium; naproxen (the active ingredients of Vimovo) and Vimovo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Aloxi and Urethral Stenosis - a second ago
- Terbutaline Sulfate and Breathing Difficulty - 3 seconds ago
- Birth Control and Hyperglycemia - 9 seconds ago
- Epinephrine and Lucentis drug interaction - 12 seconds ago
- Ticagrelor and Stress And Anxiety - 16 seconds ago
- Breast Cancer Recurrent and Urge Incontinence - 24 seconds ago
- Clofarabine and Sinus Tachycardia - 25 seconds ago
- Fluocinonide and Klor-Con M10 drug interaction - 36 seconds ago
- Lisinopril and Nephritis - Interstitial - 39 seconds ago
- Lisinopril and Interstitial Nephritis - 39 seconds ago